DiDi Global Non-Controlling Interest 2021-2025 | DIDIY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

DiDi Global annual non-controlling interest for 2024 was $0.002B, a 60.89% decline from 2023.
DiDi Global annual non-controlling interest for 2023 was $0.006B, a 4859.32% increase from 2022.
DiDi Global annual non-controlling interest for 2022 was $0B, a 91.73% decline from 2021.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

DiDi Global annual non-controlling interest for 2024 was $0.002B, a 60.89% decline from 2023.
DiDi Global annual non-controlling interest for 2023 was $0.006B, a 4859.32% increase from 2022.
DiDi Global annual non-controlling interest for 2022 was $0B, a 91.73% decline from 2021.

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$138.3B
CVS Health (CVS)	$80.7B
Elevance Health (ELV)	$77.8B
Cencora (COR)	$57.7B
Labcorp Holdings (LH)	$20.6B
Natera (NTRA)	$20.3B
BioMerieux (BMXMF)	$16.9B
EUROFINS SCIENT (ERFSF)	$13.9B
CochLear (CHEOY)	$12.8B
Solventum (SOLV)	$12.6B
ICON (ICLR)	$11.6B
Revvity (RVTY)	$11.2B
Viatris (VTRS)	$10.7B
Medpace Holdings (MEDP)	$9B
Sonic Healthcare (SKHHY)	$8.8B
Avantor (AVTR)	$8.8B
HealthEquity (HQY)	$8.4B
Caris Life Sciences,�Inc (CAI)	$8B
Charles River Laboratories (CRL)	$7.6B
Amplifon S.p.A (AMFPF)	$5.4B
Bausch + Lomb (BLCO)	$4.9B
BrightSpring Health Services (BTSG)	$3.5B
Sotera Health (SHC)	$3.2B
Surgery Partners (SGRY)	$2.9B
Alignment Healthcare (ALHC)	$2.6B
Concentras Parent (CON)	$2.5B
Organon (OGN)	$2.5B
GeneDx Holdings (WGS)	$2.3B
Progyny (PGNY)	$2B
PACS (PACS)	$1.9B